KRAS and breast cancer: Meanwhile, malignant basal-type (MDA-MB231, MDA-MB-436, and BT20) breast cancer cells had a higher expression level of KRAS compared with luminal-type breast cancer cell lines (MCF7, SKBR3, and T47D; Figure 1F).